Cisatracurium Besylate 70069-0161-10
- Manufacturer
- Somerset Therapeutics, Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 2, 2019
- Listing Expires
- December 31, 2027
- Application
- ANDA209132
Need to source Cisatracurium Besylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cisatracurium Besylate | 2 mg/mL |
Drug Class
Neuromuscular Nondepolarizing Blockade [PE]Nondepolarizing Neuromuscular Blocker [EPC]
Selected Package
70069-0161-10Selected10 VIAL, MULTI-DOSE in 1 CARTON (70069-161-10) / 10 mL in 1 VIAL, MULTI-DOSE
Other packages for this product(1)
1 VIAL in 1 CARTON (70069-161-01) / 10 mL in 1 VIAL